Print Page

給 業 界 的 信
 
Concomitant use of Opsumit® (macitentan) Film-Coated Tablet 10mg with dual moderate CYP3A4／CYP2C9 inhibitors that could result in an increase in exposure to Opsumit® (Letter to Healthcare Professionals) (English only)
 
 
 
附件:
  1. Concomitant use of Opsumit® (macitentan) Film-Coated Tablet 10mg with dual moderate CYP3A4/CYP2C9 inhibitors that could result in an increase in exposure to Opsumit® (English only)  
Related Information:
Singapore: Concomitant use of Opsumit® (macitentan) Film-Coated Tablet 10mg with... 上載於 2020-11-11
 
back